The involvement of the RB1 pathway is consistent with concurrent Rb1 and Tp53 mutation in mice, which simulates characteristics of aggressive serous ovarian cancers, including formation of ascites and metastasis [39]. The gene discussed is TP53; the disease is ovarian serous adenocarcinoma.